476 related articles for article (PubMed ID: 30253099)
21. Deciphering oncogenic drivers: from single genes to integrated pathways.
Chen J; Sun M; Shen B
Brief Bioinform; 2015 May; 16(3):413-28. PubMed ID: 25378434
[TBL] [Abstract][Full Text] [Related]
22. Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models.
Svetlichnyy D; Imrichova H; Fiers M; Kalender Atak Z; Aerts S
PLoS Comput Biol; 2015 Nov; 11(11):e1004590. PubMed ID: 26562774
[TBL] [Abstract][Full Text] [Related]
23. Sequence and structure signatures of cancer mutation hotspots in protein kinases.
Dixit A; Yi L; Gowthaman R; Torkamani A; Schork NJ; Verkhivker GM
PLoS One; 2009 Oct; 4(10):e7485. PubMed ID: 19834613
[TBL] [Abstract][Full Text] [Related]
24. Sequence Neighborhoods Enable Reliable Prediction of Pathogenic Mutations in Cancer Genomes.
Banerjee S; Raman K; Ravindran B
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34068918
[TBL] [Abstract][Full Text] [Related]
25. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
26. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
27. Pan-cancer assessment of mutational landscape in intrinsically disordered hotspots reveals potential driver genes.
Zou H; Pan T; Gao Y; Chen R; Li S; Guo J; Tian Z; Xu G; Xu J; Ma Y; Li Y
Nucleic Acids Res; 2022 May; 50(9):e49. PubMed ID: 35061901
[TBL] [Abstract][Full Text] [Related]
28. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
Elife; 2021 Jan; 10():. PubMed ID: 33427197
[TBL] [Abstract][Full Text] [Related]
29. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
30. A novel network control model for identifying personalized driver genes in cancer.
Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
[TBL] [Abstract][Full Text] [Related]
31. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
32. Altered oncomodules underlie chromatin regulatory factors driver mutations.
Frigola J; Iturbide A; Lopez-Bigas N; Peiro S; Gonzalez-Perez A
Oncotarget; 2016 May; 7(21):30748-59. PubMed ID: 27095575
[TBL] [Abstract][Full Text] [Related]
33. An integrated deep learning and dynamic programming method for predicting tumor suppressor genes, oncogenes, and fusion from PDB structures.
Anandanadarajah N; Chu CH; Loganantharaj R
Comput Biol Med; 2021 Jun; 133():104323. PubMed ID: 33934067
[TBL] [Abstract][Full Text] [Related]
34. Uncovering driver genes in breast cancer through an innovative machine learning mutational analysis method.
Taheri G; Habibi M
Comput Biol Med; 2024 Mar; 171():108234. PubMed ID: 38430742
[TBL] [Abstract][Full Text] [Related]
35. Driver gene classification reveals a substantial overrepresentation of tumor suppressors among very large chromatin-regulating proteins.
Waks Z; Weissbrod O; Carmeli B; Norel R; Utro F; Goldschmidt Y
Sci Rep; 2016 Dec; 6():38988. PubMed ID: 28008934
[TBL] [Abstract][Full Text] [Related]
36. DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features.
Lyu J; Li JJ; Su J; Peng F; Chen YE; Ge X; Li W
Sci Adv; 2020 Nov; 6(46):. PubMed ID: 33177077
[TBL] [Abstract][Full Text] [Related]
37. Evaluating machine learning methodologies for identification of cancer driver genes.
Malebary SJ; Khan YD
Sci Rep; 2021 Jun; 11(1):12281. PubMed ID: 34112883
[TBL] [Abstract][Full Text] [Related]
38. Novel ratio-metric features enable the identification of new driver genes across cancer types.
Sudhakar M; Rengaswamy R; Raman K
Sci Rep; 2022 Jan; 12(1):5. PubMed ID: 34997044
[TBL] [Abstract][Full Text] [Related]
39. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
40. EPIMUTESTR: a nearest neighbor machine learning approach to predict cancer driver genes from the evolutionary action of coding variants.
Parvandeh S; Donehower LA; Panagiotis K; Hsu TK; Asmussen JK; Lee K; Lichtarge O
Nucleic Acids Res; 2022 Jul; 50(12):e70. PubMed ID: 35412634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
